Searchable abstracts of presentations at key conferences in endocrinology

ea0046p30 | (1) | UKINETS2016

Evaluating the impact of the Specialist Nurse

Wotherspoon Irene

The Beatson West of Scotland Cancer Centre (BWoSCC) is a Regional Service for the West of Scotland and beyond. It is considered to be a Centre of Excellence in the delivery of 21st century cancer care.Whilst the role of site specific specialist nurses has been integral to many cancer teams for in excess of 20 years, this has not been the case for neuroendocrine tumours in Scotland until May 2016.An international study ca...

ea0068p27 | Abstracts | UKINETS2019

The impact of telotristat in the west and east of Scotland

Gibson Katie , Wotherspoon Irene

Explosive, multiple episodes of diarrhoea are common in patients with neuroendocrine neoplasms affecting around 30% of the patient population. This is combination with other symptoms such as red, dry flushing and wheezing constitute carcinoid syndrome. This syndrome can have a devastating effect on patients impacting upon all aspects of their being. Somatostatin analogues alone can be successful in the management of diarrhoea however in some cases this is inadequate. In 2018 T...

ea0105p5 | Poster Presentations | UKINETS2024

Management of cold sepsis in a patient receiving peptide radionuclide receptor treatment (PRRT): a case review

Wotherspoon Irene , Beattie Olivia

The Beatson West of Scotland Cancer delivers all PRRT to patients in Scotland. Approximately 4 patients are treated per week in a ward specially designed for the administration of radionuclide treatments. Pre treatment assessment is an essential part of the care and the patient in this case was identified as fit, well with bloods within normal range and a performance status of 0. Within a few hours of treatment administration the patient became unwell and was found to have col...

ea0096p7 | Section | UKINETS2023

Findings of a retrospective data analysis on outcome of temozolomide singe agent and temozolomide/capecitabine in patients with gastroenteropancreatic neuroendocrine neoplasms (gep-nen) in the european neuroendocrine tumour centre of excellence at the beatson west of scotland cancer centre, glasgow

Irene Wotherspoon Sister , Martin Dr. Amy , McIntosh Dr. DAvid , Reed Prof Nick

Approximately 230 new patients with GEP-NEN are referred annually to the centre. Prevalence of GEP-NEN is increasing due to the availability of 2nd, 3rd or 4th line treatments. Oral chemotherapy is being used with increasing frequency in this setting. The NEN Team wished to explore the outcomes of patients treated with temozolomide singe agent and temozolomide/capecitabine during the previous 5 years and compare the findings with current literature. 18 patients were included i...